Get started
Author

Alexandre Sayadi

Observed name: A. Sayadi
Institutions: Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris, Centre de Recherche sur l'Inflammation, Bicêtre Hospital, Structure fédérative de recherche Necker
Observed institutions: Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Université Paris-Saclay, Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris, Hôpital Avicenne, Centre de Recherche sur l'Inflammation, Hôpitaux Universitaires Henri-Mondor, Hôpital Albert-Chenevier, Bicêtre Hospital, Hôpital Paul-Brousse, Méthodes et Outils pour les Sciences Participatives, Structure fédérative de recherche Necker
ORCID: 0000-0003-4377-9926
Observed ORCID: 0000-0003-4377-9926
OpenAlex ID: A5000445920
TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2024 · Grégoire Gessain, Ahmed-Amine Anzali, et al. · Cancer Discovery · 20
Hepato-pulmonary syndrome
2023 · Delphine Weil, Alexandre Sayadi, et al. · Hépato-Gastro & Oncologie Digestive · 17
Syndrome hépato-pulmonaire
2023 · A. Sayadi, L. Duhaut, et al. · La Revue de Médecine Interne · 6
Vessels encapsulating tumor clusters predict better outcomes in advanced hepatocellular carcinoma treated with atezolizumab–bevacizumab
2026 · Alexandre Sayadi, Claudia Campani, et al. · JHEP Reports · 3
PDF
SAT-344-YI Long-term outcome of sinusoidal obstruction syndrome secondary to hematopoietic stem cell transplantation
2025 · Edilmar Alvarado-Tapias, Alexandre Sayadi, et al. · Journal of Hepatology · 3
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF
2026 · Virginia Hernandez-Gea, Valerie Paradis, et al. · Hepatology International · 2
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF
2026 · Virginia Hernández-Gea, Valerie Paradis, et al. · Journal of Hepatology · 2
PDF
OS-083-YI Evidence-based definition of major and minor histological criteria for the diagnosis of porto-sinusoidal vascular disease
2026 · Alexandre Sayadi, Christine Sempoux, et al. · Journal of Hepatology · 2
Figure S1 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2024 · Grégoire Gessain, Ahmed-Amine Anzali, et al. · 1
Supplementary Table S9 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2024 · Grégoire Gessain, Ahmed-Amine Anzali, et al. · 1
Data from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2024 · Grégoire Gessain, Ahmed-Amine Anzali, et al. · 1
Histopathological Integrity of an Explanted Human Liver with Hepatocellular Carcinoma after Normothermic Perfusion
2026 · Sadaf Barakzoy, Elie Farha, et al. · Journal of Clinical and Translational Hepatology
PDF
Synthesis, Biological Evaluation, and Biodistribution of Xinyne, a Novel Quinazoline–carbazole N -methylamine Anticancer Agent Used in Mice Xenograft Models
2026 · Xinya Liu, Justyne Feat-Vetel, et al. · Journal of Medicinal Chemistry
Long-term outcome of sinusoidal obstruction syndrome secondary to hematopoietic stem cell transplantation
2026 · Edilmar Alvarado-Tapias, Alexandre Sayadi, et al. · JHEP Reports
Figure S7 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Figure S8 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Figure S4 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Supplementary Table S8 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Figure S10 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Figure S3 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Figure S2 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Figure S9 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Figure S5 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Figure S1 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Figure S6 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
2026 · Grégoire Gessain, Ahmed-Amine Anzali, et al.
Works count: 50
Citation count: 58
H-index: 3
I10-index: 2
Year
Topic
Type